Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$83.10 -0.34 (-0.41%)
At close: Oct 22, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Preferred Stock Liabilities (2018 - 2019)

Updated

Mirum Pharmaceuticals' Preferred Stock Liabilities was $126.82 million in Q2 2019, up 89.7% from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Preferred Stock Liabilities at Mirum Pharmaceuticals came in at $66.84 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Mirum Pharmaceuticals 5.25 Bn 3.67 Bn 145.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 126.82 Mn
Mar 31, 2019 66.84 Mn
Dec 31, 2018 66.84 Mn
API Access

Mirum Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=MIRM&period=max&api_key=YOUR_API_KEY